Question 1

What is PeptiDream?

Accepted Answer

PeptiDream is a Company.

Question 2

How often does PeptiDream appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was PeptiDream first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was PeptiDream last mentioned in news?

Accepted Answer

Last active on Jun 11, 2026.

Question 5

What is PeptiDream's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is PeptiDream in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving PeptiDream?

Accepted Answer

Curium, PeptiDream complete prostate cancer trial (Jun 11, 2026, 6 articles).

Question 8

How did the "Curium, PeptiDream complete prostate cancer trial" event impact PeptiDream?

Accepted Answer

PeptiDream, through its subsidiary PDRadiopharma, is a crucial partner in the clinical trial, leading regulatory filing, manufacturing, commercialization, and distribution activities in Japan. The completion of patient dosing marks an important milestone in its growing radiopharmaceutical pipeline and theranostics strategy.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.